Controlled Release from Solid Pharmaceutical Formulations of two Nalkanoyl- 4-methoxybicyclo[4.2.0]octa-1,3,5-trien-7-ethanamines with Melatoninergic Activity

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|12|4|259-262

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.12, Iss.4, 2015-05, pp. : 259-262

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Studies on controlled release dimenhydrinate from matrix tablet formulations

By Genc L.   Bilac H.   Guler E.  

Pharmaceutica Acta Helvetiae, Vol. 74, Iss. 1, 1999-12 ,pp. : 43-49

Elsevier

Access to resources Recommend Favorite

Influence of Alcohol on the Release of Tramadol from 24-h Controlled-Release Formulations During In Vitro Dissolution Experiments

By Traynor M. J.   Brown M. B.   Pannala A.   Beck P.   Martin G. P.  

Drug Development and Industrial Pharmacy, Vol. 34, Iss. 8, 2008-08 ,pp. : 885-889

Informa Healthcare

Access to resources Recommend Favorite

Effects of Dissolution Medium Composition on Ropinirole Release from Slow-Release Solid Dosed Formulations

By Yarushok T.   Shokhin I.   Medvedev Yu.  

Pharmaceutical Chemistry Journal, Vol. 47, Iss. 8, 2013-11 ,pp. : 442-445

Springer Publishing Company

Access to resources Recommend Favorite

Design and Study of Rifampicin Oral Controlled Release Formulations

By Hiremath S.   Saha R.  

Drug Delivery, Vol. 11, Iss. 5, 2004-09 ,pp. : 311-317

Informa Healthcare

Access to resources Recommend Favorite

Development of Controlled Release Sildenafil Formulations for Vaginal Administration

By Değim I. Tuncer   Tuğcu-Demiröz Fatmanur   Tamer-Ilbasmıs Sibel   Acartürk Füsun  

Drug Delivery, Vol. 15, Iss. 4, 2008-05 ,pp. : 259-265

Informa Healthcare

Access to resources Recommend Favorite